- Shoppers
Drug Mart is now the exclusive direct-to-patient online provider of
FlowrRx products
- The
agreement between Flowr Corporation and Shoppers Drug Mart is expected to
solidify Flowr’s leading position in the Canadian medicinal cannabis
market
- Flowr
is already a leader in terms of high yields and low production costs – two
factors that are proving to be determining for the success of cannabis
companies
FlowrRX products by The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) are
now available for purchase through the Shoppers Drug Mart online medical
cannabis platform, as the company announced on March 18, 2019 (http://ibn.fm/rV9dS).
The two companies confirmed a sales agreement at the
beginning of 2019. Through the partnership, The Flowr Corporation and Shoppers
Drug Mart are simplifying the delivery of medical cannabis products in Canada.
“Flowr’s premium medical cannabis is grown in what we
believe is the industry’s most advanced GMP designed cultivation facility. This
relationship is testament to our commitment to ultra-high-quality cannabis
cultivation and further solidifies Flowr’s role in Canada’s medical cannabis
landscape,” co-CEO Vinay Tolia said in a news release.
To order FlowerRX products, patients are required to submit
a completed medical document from a health care practitioner to Shoppers Drug
Mart. Company advisers will next contact the health care practitioner to verify
the document and ensure the immediate completion of the order.
Previously, FlowrRX products were available via the Flowr
online store. As per a 2019 agreement, Shoppers Drug Mart is now the exclusive
direct-to-patient distributor of FlowrRX products.
Featuring premium quality medicinal cannabis, the FlowrRX
range of offerings is the result of Flowr Corporation’s research and
development team focusing on innovative cultivars and the creation of unique
products. High quality customer service is another key to the delivery of
reliable solutions under the FlowrRX brand.
The FlowrRX premium product delivery program incorporates
the use of multiple strains ranging from high THC to more balanced options and
featuring the company’s BC Delahaze. Delahaze is an award-winning cultivar
known for the strong invigorating effect. The cultivar is grown in the Flowr
Corporation’s indoor facility to put emphasis on both potency and flavor
through consistent control over the cultivation process.
Flowr Corporation is a Health Canada Licensed Producer of
cannabis under the Access to Cannabis for Medical Purposes Regulations. The
company is emerging as a Canadian leader in the field as a result of its highly
advanced, purpose-built cultivation facilities.
Through its innovative cultivation practices, Flowr
consistently generates the high crop yields needed for the delivery of premium
and ultra-premium cannabis products.
Control over cultivation and innovative practices result in
a cost-efficient cultivation process. As the company notes, high yields per
square foot are key to ensuring low operating costs and profitability.
For more information, visit the company’s website at www.Flowr.ca
NOTE TO INVESTORS: The latest news and updates
relating to FLPWF are available in the company’s newsroom at http://ibn.fm/FLWPF
About QualityStocks
QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential. We offer several ways for investors to learn more
about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment